To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst
February 16, 2021 at 08:27 AM EST
Investors seeking to profit from the merger of Canadian cannabis companies Tilray Inc. and Aphria Inc. are best to do so by buying shares of Aphria, which are trading at a 51% discount over the merger conversion price, Cantor Fitzgerald analyst Pablo Zuanic said Tuesday.
